• Supernus Pharmaceuticals (NASDAQ:SUPN) Lowered to "Buy" Rating by StockNews.com

    来源: Buzz FX / 28 2月 2025 21:21:14   America/Chicago


    Supernus Pharmaceuticals (NASDAQ:SUPN) Lowered to "Buy" Rating by StockNews.com Written by MarketBeat February 28, 2025 Share Link copied to clipboard. Supernus Pharmaceuticals ( NASDAQ:SUPN - Get Free Report ) was downgraded by StockNews.c
    Read more...
分享